Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Limited Access Phase II Trial Utilizing Bioimpedance to Measure Lower Extremity Lymphedema Associated With the Surgical Management of a Vulvar Cancer

NCT01406769 is registered in ClinicalTrials.gov with Gynecologic Oncology Group as lead sponsor.

NCT NCT01406769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01406769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Limited Access Phase II Trial Utilizing Bioimpedance to Measure Lower Extremity Lymphedema Associated With the Surgical Management of a Vulvar Cancer
Lead sponsor
Gynecologic Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
July 16, 2012
Completion date
April 10, 2020
Enrollment
120 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

lymphedema, perioperative/postoperative complications, stage ia vulvar cancer ajcc v7, stage ib vulvar cancer ajcc v7, stage ii vulvar cancer ajcc v7, stage iiia vulvar cancer ajcc v7, stage iiib vulvar cancer ajcc v7, stage iiic vulvar cancer ajcc v7, stage iva vulvar cancer ajcc v7, stage ivb vulvar cancer ajcc v6 and v7